We are live on ! Find out more
WVE icon

Wave Life Sciences
WVE

92 hedge funds and large institutions have $1.19B invested in Wave Life Sciences in 2018 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 25 increasing their positions, 27 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

156% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 9

27% more capital invested

Capital invested by funds: $936M → $1.19B (+$254M)

18% more funds holding

Funds holding: 78 → 92 (+14)

0% more funds holding in top 10

Funds holding in top 10: 5 → 5 (0)

7% less repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 27

2.86% less ownership

Funds ownership: 84.04% → 81.18% (-2.9%)

Holders
92
Holders Change
+14
Holders Change %
+17.95%
% of All Funds
2.1%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.11%
New
23
Increased
25
Reduced
27
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BB
BB Biotech
Switzerland
+$11.1M
2
Invesco
Invesco
Georgia
+$7.96M
3
Millennium Management
Millennium Management
New York
+$3.9M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$2.26M
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$1.45M

Top Sellers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
-$16.6M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$12.6M
3
EAM
Eventide Asset Management
Massachusetts
-$7.04M
4
DM
Deerfield Management
New York
-$6.84M
5
BM
Bridger Management
New York
-$6.62M
Name Holding Trade Value Shares
Change 		Change in
Stake
WM
26
WS Management
Florida
$5.6M – – –
D.E. Shaw & Co
27
D.E. Shaw & Co
New York
$5.46M +$1.41M +31,142 +40%
Charles Schwab
28
Charles Schwab
California
$4.52M +$316K +7,003 +8%
Millennium Management
29
Millennium Management
New York
$4.32M +$3.9M +86,349 New
Bank of New York Mellon
30
Bank of New York Mellon
New York
$3.49M +$29.7K +659 +1%
Deutsche Bank
31
Deutsche Bank
Germany
$3.48M -$1.73M -38,261 -35%
CCP
32
Clough Capital Partners
Massachusetts
$3.42M -$2.79M -61,800 -48%
EU
33
Emory University
Georgia
$2.82M -$520K -11,522 -17%
FCMI
34
Foresite Capital Management III
California
$2.5M -$1.13M -25,000 -33%
DCM
35
DAFNA Capital Management
California
$2.4M – – –
EC
36
EcoR1 Capital
California
$2.24M -$16.6M -368,030 -89%
MC
37
Matisse Capital
Oregon
$2.12M +$229K +5,085 +14%
TA
38
Teachers Advisors
New York
$1.77M +$291K +6,453 +22%
TCIM
39
TIAA CREF Investment Management
New York
$1.63M -$133K -2,947 -8%
Morgan Stanley
40
Morgan Stanley
New York
$1.63M -$285K -6,323 -16%
PIM
41
Platinum Investment Management
Australia
$1.61M – – –
PPA
42
Parametric Portfolio Associates
Washington
$1.36M +$114K +2,532 +10%
California State Teachers Retirement System (CalSTRS)
43
California State Teachers Retirement System (CalSTRS)
California
$1.35M -$451 -10 -0%
Goldman Sachs
44
Goldman Sachs
New York
$1.14M -$68.9K -1,528 -6%
PP
45
PDT Partners
New York
$1.07M -$743K -16,476 -43%
B
46
Bailard
California
$1.03M -$271K -6,000 -22%
SSA
47
Schonfeld Strategic Advisors
New York
$1M -$451K -10,000 -33%
New York State Common Retirement Fund
48
New York State Common Retirement Fund
New York
$980K – – –
Swiss National Bank
49
Swiss National Bank
Switzerland
$970K – – –
AllianceBernstein
50
AllianceBernstein
Tennessee
$935K – – –
1
2
3 4 5

WVE Hedge Fund Activity: Q3 2018 in Review

92 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Wave Life Sciences (WVE) for Q3 2018, worth a combined $1.19B — up 27% from $936M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new WVE positions and 9 closed out — a net gain of 14 holders — while 25 added to existing stakes and 27 trimmed.

The largest buyer was BB Biotech, adding an estimated $11.1M. The largest seller was EcoR1 Capital, cutting an estimated $16.6M.

  • 92 institutional investors held Wave Life Sciences (WVE) as of Q3 2018, up from 78 in Q2 2018.
  • Funds reported $1.19B of Wave Life Sciences stock for Q3 2018, up 27% quarter-over-quarter.
  • 23 funds opened new Wave Life Sciences positions in Q3 2018 and 9 closed out, a net change of +14 holders.
  • The largest Wave Life Sciences buyer in Q3 2018 was BB Biotech, an estimated $11.1M added.
  • The largest Wave Life Sciences seller in Q3 2018 was EcoR1 Capital, an estimated $16.6M sold.

Based on aggregated 13F filings for Q3 2018.